Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | -0.3x - -0.4x | -0.3x |
| Selected Fwd EBIT Multiple | 0.1x - 0.1x | 0.1x |
| Fair Value | €3.14 - €3.29 | €3.22 |
| Upside | 29.8% - 36.1% | 33.0% |
| Benchmarks | Ticker | Full Ticker |
| Simply Better Brands Corp. | SBBC.F | OTCPK:SBBC.F |
| Tilray Brands, Inc. | TLRY | NasdaqGS:TLRY |
| CannaPharmaRX, Inc. | CPMD | OTCPK:CPMD |
| InnoCan Pharma Corporation | INNP.F | OTCPK:INNP.F |
| IntelGenx Technologies Corp. | IGXT | OTCPK:IGXT |
| InMed Pharmaceuticals Inc. | MWG | DB:MWG |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| SBBC.F | TLRY | CPMD | INNP.F | IGXT | MWG | ||
| OTCPK:SBBC.F | NasdaqGS:TLRY | OTCPK:CPMD | OTCPK:INNP.F | OTCPK:IGXT | DB:MWG | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | |
| 3Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | |
| Latest Twelve Months | -0.5% | 39.6% | 74.8% | 71.7% | -4.0% | -11.0% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | -11.3% | -20.9% | -4035.7% | -5536.6% | -913.0% | -934.2% | |
| Prior Fiscal Year | -14.8% | -27.7% | NA | -244.9% | -990.8% | -202.6% | |
| Latest Fiscal Year | -13.3% | -12.2% | NA | -27.8% | -913.5% | -176.9% | |
| Latest Twelve Months | -8.4% | -12.0% | -408.2% | -4.2% | -961.7% | -160.7% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 0.83x | 0.86x | 38.84x | 1.36x | 42.68x | -0.01x | |
| EV / LTM EBITDA | -15.6x | 22.9x | -10.2x | -33.3x | -4.8x | 0.0x | |
| EV / LTM EBIT | -9.9x | -7.2x | -9.5x | -32.3x | -4.4x | 0.0x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -32.3x | -9.5x | -4.4x | ||||
| Historical EV / LTM EBIT | -2.4x | -0.3x | 0.6x | ||||
| Selected EV / LTM EBIT | -0.3x | -0.3x | -0.4x | ||||
| (x) LTM EBIT | (8) | (8) | (8) | ||||
| (=) Implied Enterprise Value | 2 | 3 | 3 | ||||
| (-) Non-shareholder Claims * | 3 | 3 | 3 | ||||
| (=) Equity Value | 5 | 5 | 5 | ||||
| (/) Shares Outstanding | 1.4 | 1.4 | 1.4 | ||||
| Implied Value Range | 3.64 | 3.73 | 3.83 | ||||
| FX Rate: USD/EUR | 1.1 | 1.1 | 1.1 | Market Price | |||
| Implied Value Range (Trading Cur) | 3.36 | 3.45 | 3.54 | 2.42 | |||
| Upside / (Downside) | 38.9% | 42.5% | 46.1% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | SBBC.F | TLRY | CPMD | INNP.F | IGXT | MWG | |
| Enterprise Value | 72 | 716 | 13 | 31 | 45 | 1 | |
| (+) Cash & Short Term Investments | 4 | 252 | 0 | 5 | 1 | 3 | |
| (+) Investments & Other | 0 | 7 | 5 | 0 | 0 | 0 | |
| (-) Debt | (6) | (374) | (14) | (0) | (16) | (1) | |
| (-) Other Liabilities | 0 | 19 | 0 | (2) | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | (1) | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 71 | 621 | 3 | 34 | 29 | 4 | |
| (/) Shares Outstanding | 107.2 | 937.7 | 656.3 | 260.4 | 174.7 | 1.4 | |
| Implied Stock Price | 0.66 | 0.66 | 0.00 | 0.13 | 0.17 | 2.62 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.08 | |
| Implied Stock Price (Trading Cur) | 0.66 | 0.66 | 0.00 | 0.13 | 0.17 | 2.42 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.08 | |